BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32319528)

  • 1. Pharmacokinetic Comparison of a Novel Non-tobacco-Based Nicotine Pouch (ZYN) With Conventional, Tobacco-Based Swedish Snus and American Moist Snuff.
    Lunell E; Fagerström K; Hughes J; Pendrill R
    Nicotine Tob Res; 2020 Oct; 22(10):1757-1763. PubMed ID: 32319528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harmful and potentially harmful constituents (HPHCs) in two novel nicotine pouch products in comparison with regular smokeless tobacco products and pharmaceutical nicotine replacement therapy products (NRTs).
    Back S; Masser AE; Rutqvist LE; Lindholm J
    BMC Chem; 2023 Mar; 17(1):9. PubMed ID: 36869349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steady-state nicotine plasma levels following use of four different types of Swedish snus compared with 2-mg Nicorette chewing gum: a crossover study.
    Lunell E; Lunell M
    Nicotine Tob Res; 2005 Jun; 7(3):397-403. PubMed ID: 16085507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine delivery and subjective effects of Swedish portion snus compared with 4 mg nicotine polacrilex chewing gum.
    Lunell E; Curvall M
    Nicotine Tob Res; 2011 Jul; 13(7):573-8. PubMed ID: 21454913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Emerging and Conventional Oral Tobacco Among Adolescent and Young Adult E-Cigarette Users.
    Couch ET; Halpern-Felsher B; Werts M; Chaffee BW
    Subst Use Misuse; 2023; 58(2):283-288. PubMed ID: 36645845
    [No Abstract]   [Full Text] [Related]  

  • 6. Characteristics of "American Snus" and Swedish Snus Products for Sale in Massachusetts, USA.
    Seidenberg AB; Ayo-Yusuf OA; Rees VW
    Nicotine Tob Res; 2018 Jan; 20(2):262-266. PubMed ID: 28003512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Total and Unprotonated (Free) Nicotine Content of Nicotine Pouch Products.
    Stanfill S; Tran H; Tyx R; Fernandez C; Zhu W; Marynak K; King B; Valentín-Blasini L; Blount BC; Watson C
    Nicotine Tob Res; 2021 Aug; 23(9):1590-1596. PubMed ID: 34233354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products: a comparative study.
    Andersson G; Björnberg G; Curvall M
    J Oral Pathol Med; 1994 Apr; 23(4):161-7. PubMed ID: 8046653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative Risk Perceptions between Snus and Cigarettes in a Snus-Prevalent Society-An Observational Study over a 16 Year Period.
    Lund KE; Vedoy TF
    Int J Environ Res Public Health; 2019 Mar; 16(5):. PubMed ID: 30862006
    [No Abstract]   [Full Text] [Related]  

  • 10. Tobacco-Derived Nicotine Pouch Brands and Marketing Messages on Internet and Traditional Media: Content Analysis.
    Ling PM; Hrywna M; Talbot EM; Lewis MJ
    JMIR Form Res; 2023 Feb; 7():e39146. PubMed ID: 36790840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use, marketing, and appeal of oral nicotine products among adolescents, young adults, and adults.
    Gaiha SM; Lin C; Lempert LK; Halpern-Felsher B
    Addict Behav; 2023 May; 140():107632. PubMed ID: 36731224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Swedish snus and the Sudanese toombak: are they different?
    Idris AM; Ibrahim SO; Vasstrand EN; Johannessen AC; Lillehaug JR; Magnusson B; Wallström M; Hirsch JM; Nilsen R
    Oral Oncol; 1998 Nov; 34(6):558-66. PubMed ID: 9930371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a non-tobacco-based nicotine pouch on mucosal lesions caused by Swedish smokeless tobacco (snus).
    Alizadehgharib S; Lehrkinder A; Alshabeeb A; Östberg AK; Lingström P
    Eur J Oral Sci; 2022 Aug; 130(4):e12885. PubMed ID: 35853092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Openness to Using Non-cigarette Tobacco Products Among U.S. Young Adults.
    Mays D; Arrazola RA; Tworek C; Rolle IV; Neff LJ; Portnoy DB
    Am J Prev Med; 2016 Apr; 50(4):528-534. PubMed ID: 26549502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine pouch marketing strategies in the USA: an analysis of Zyn, On! and Velo.
    Duan Z; Henriksen L; Vallone D; Rath JM; Evans WD; Romm KF; Wysota C; Berg CJ
    Tob Control; 2024 Feb; 33(2):154-163. PubMed ID: 35817549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the public health impact had tobacco-free nicotine pouches been introduced into the US in 2000.
    Lee PN; Fry JS; Ljung T
    BMC Public Health; 2022 May; 22(1):1025. PubMed ID: 35597944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels.
    Stepanov I; Jensen J; Hatsukami D; Hecht SS
    Nicotine Tob Res; 2008 Dec; 10(12):1773-82. PubMed ID: 19023828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsmokers' responses to new warning labels on smokeless tobacco and electronic cigarettes: an experimental study.
    Popova L; Ling PM
    BMC Public Health; 2014 Sep; 14():997. PubMed ID: 25253295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in nicotine intake and oral mucosal changes among users of Swedish oral moist snuff after switching to a low-nicotine product.
    Andersson G; Axéll T; Curvall M
    J Oral Pathol Med; 1995 Jul; 24(6):244-50. PubMed ID: 7562659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in Awareness, Use of, and Beliefs About Electronic Cigarette and Snus Among a Longitudinal Cohort of US Midwest Young Adults.
    Choi K; Bestrashniy J; Forster J
    Nicotine Tob Res; 2018 Jan; 20(2):239-245. PubMed ID: 28199683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.